DAWN News and Press, Day One Biopharmaceuticals Inc. From 04/06/22

SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that ma...

Day One Biopharmaceuticals press release (NASDAQ:DAWN): FY GAAP EPS of -$4.62 misses by $0.85. Cash and cash equivalents totaled $284.3 million on December 31, 2021. For further details see: Day One Biopharmaceuticals GAAP EPS of -$4.62 misses by $0.85

Initial data from pivotal FIREFLY-1 study with DAY101 (tovorafenib) expected in June 2022 Targeted enrollment achieved in pivotal FIREFLY-1 study Topline results from pivotal FIREFLY-1 study expected in Q1 2023 Current cash provides runway into 2024 and through multiple expect...

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced manageme...

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that Dr....

After a decline of more than 10% on Wednesday, Day One Biopharmaceuticals (DAWN +18.4%) is trading sharply higher to post the biggest intraday gain since its IPO in May. About 113.7K company shares have changed hands compared to the 65-day average volume of ~105.1K shares. The small-cap biote...

Gainers: Ardelyx ARDX +38%. Biofrontera  BFRI +21%. Jowell Global  (NASDAQ:JWEL) +19%. Duluth Holdings  DLTH +17%. Day One Biopharmaceuticals (NASDAQ:DAWN) +17%. Losers: Tantech Holdings TANH -57%. Kirkland's KIRK -27%. Context Therapeutics&#x...

Gainers: Biofrontera (NASDAQ:BFRI) +36%. CF Acquisition (NASDAQ:CFVIU) +19%. Day One (NASDAQ:DAWN) +16%. Terns Pharmaceuticals (NASDAQ:TERN) +15%. Duluth Holdings (NASDAQ:DLTH) +15%. Snowflake (NYSE:SNOW) +14%. Aurinia Pharmaceuticals (NASDAQ:AUPH) +14%. Express (NYSE:EXPR) +13%. Vor Biopharm...

Phase 1b/2 Study Evaluating DAY101 in Combination with Pimasertib, Day One’s MEK Inhibitor, Expected to Begin in First Quarter of 2022 SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical ...

Day One Biopharmaceuticals (NASDAQ:DAWN): Q3 GAAP EPS of -$0.33 misses by $0.07. Cash and cash equivalents and short-term investments totaled $297.2M at September 30, 2021. Press Release For further details see: Day One Biopharmaceuticals EPS misses by $0.07